Table 2 Age adjusted odds ratios
Variable | Main outcome of interest | ||||
|---|---|---|---|---|---|
No AKI | Presence of AKI | Unadjusted OR (95% CI) | Age adjusted OR (95% CI) | ||
Number (%) | Number (%) | P-value | |||
Age in years | |||||
1. 18–29 | 117 (36.11) | 16 (25.40) | Reference: | ||
2. 30–39 | 100 (30.86) | 14 (22.22) | 1.02 (0.48-2.20) | 0.573 | |
3. 40–49 | 54 (16.67) | 16 (25.40) | 2.17 (1.01-4.65) | 0.069 | |
4. 50–59 | 20 (6.17) | 5 (7.94) | 1.83 (0.60-5.55) | 0.274 | |
5. >59 | 33 (10.19) | 12 (19.05) | 2.66 (1.15-6.17) | 0.023 | |
Use of herbs | |||||
1. Yes | 82 (25.31) | 18 (28.57) | |||
2. No | 242 (74.69) | 45 (71.43) | 0.85 (0.46-1.55) | 1.05 (0.55-2.03) | 0.875 |
Postural difference (mmHg) | |||||
1. 1 | 215 (66.36) | 39 (61.90) | Reference | Reference | |
2. 2–9 | 74 (22.84) | 9 (14.29) | 0.67 (0.31-1.45) | 0.58 (0.25-1.36) | 0.213 |
3. >9 | 35 (10.80) | 15 (23.81) | 2.36 (1.18-4.73) | 1.84 (0.89-3.87) | 0.106 |
Glascow coma scale | |||||
1. ≤14 | 51 (15.74) | 23 (36.51) | |||
2. >14 | 273 (84.26) | 40 (63.49) | 0.32 (0.18-0.59) | 0.47 (0.24-0.94) | 0.032 |
Karnofsky performance score | |||||
1. ≤50 | 232 (71.83) | 50 (79.37) | |||
2. >51 | 91 (28.17) | 13 (20.63) | 0.66 (0.34-1.28) | 0.94 (0.46-1.92) | 0.864 |
Urine output (L/24 hrs) | |||||
1. ≤0.5 | 22 (6.79) | 17 (26.98) | Reference | Reference | |
2. 0.6-2.4 | 285 (87.96) | 43 (68.25) | 0.20 (0.10-0.40) | 0.34 (0.15-0.75) | 0.008 |
3. >2.4 | 17 (5.25) | 3 (4.76) | 0.23 (0.06-0.91) | 0.56 (0.14-2.18) | 0.401 |
Intravenous fluids (Litres) | |||||
1. ≤1 | 291 (89.81) | 55 (87.30) | |||
2. >1 | 33 (10.19) | 8 (12.70) | 1.28 (0.56-2.93) | 0.67 (0.42-2.73) | 0.422 |
White blood cell counts | |||||
1. ≤12,000 cells/mcL | 277 (85.49) | 44 (69.84) | |||
2. >12,000 cells/mcL | 47 (14.51) | 19 (30.16) | 2.54 (1.37-4.73) | 2.24 (1.11-4.52) | 0.024 |
Platelets | |||||
1. ≤100,000 cells/mcL | 45 (13.89) | 10 (15.87) | |||
2. >100,000 cells/mcL | 279 (86.11) | 53 (84.13) | 0.85 (0.41-1.80) | 0.73 (0.34-1.56) | 0.415 |